Research programme: mitochondrial disorders therapeutics - KhondrionAlternative Names: KG 183; KH 744; KH183
Latest Information Update: 29 Jul 2016
At a glance
- Originator Khondrion
- Class Small molecules
- Mechanism of Action Reactive oxygen species modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Mitochondrial disorders
Most Recent Events
- 29 Jul 2016 Preclinical trials in Mitochondrial disorders in Netherlands (unspecified route)